Increasing aging populations and growing hospital infrastructures will drive demand for rheumatoid arthritis drugs.Wilmington ...

A new treatment involving radiation launched three years ago, but only a small number of vets have access to ... In ...

Semaglutide shows promise in treating knee osteoarthritis by reducing pain and weight, offering a safe alternative to traditional pharmacological interventions.

People who received weekly injections of semaglutide -- the active agent in the diabetes drug Ozempic and the weight-loss ...

A non-opioid drug for pain developed by UK biotech Levicept, with a new mechanism of action, has shown it can reduce pain associated with osteoarthritis in a phase 2 trial. Neurotrophin-3 (NT-3 ...

Drugmaker Viatris beat Wall Street estimates for third-quarter profit and revenue on Thursday, helped by strong demand for its new generic asthma and ADHD drugs, among others, sending its shares up 2.

A new study reported in the New England Journal of Medicine found that GLP-1 drugs such as Ozempic and Wegovy which have ...

Recent research has found that semaglutide injections, which also include controversial weight loss drug Ozempic, can reduce ...

Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA ... concomitant medications and illnesses, dates of studies performed ...

The European Alliance of Associations for Rheumatology, in partnership with the Pediatric Rheumatology European Society (PReS ...

Osteoarthritis of the knee is a common and often painful condition affecting millions worldwide, especially older adults. As ...